-
Report details
-
13
Figures
-
77
Tables
-
Chapter One: Executive Summary
-
IVD Procedure Volume Estimate and Forecast
-
Scope & Methodology
-
Chapter Two: Introduction
-
Scope
-
Overview
-
Industry Trends
-
Demographic Trends
-
Global Population and Aging
-
Workforce Reduction
-
Increase in Chronic Diseases
-
Personalized Medicine
-
High-Consequence Disease Threats
-
Tickborne Diseases (TBDs)
-
Zika
-
Chagas
-
IVD Vendors Active in Chagas Diagnostics
-
Dengue
-
Ebola
-
Chikungunya
-
Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
-
Marburg
-
Monkeypox
-
Emerging and Emerged Markets
-
Where Are the Best Markets?
-
Economic Growth and the Expanding Middle Class
-
Chapter Three: IVD Testing Segments
-
IVD Testing Trends
-
Segment Growth Projections
-
Point-of-Care (POC) Testing
-
Clinical Chemistry
-
Immunoassays
-
Mass Spectrometry (Immuno)
-
Molecular Assays
-
Hematology
-
Coagulation
-
Conventional Microbiology
-
Blood Grouping/Typing
-
Histology/Cytology
-
Segment Product Sales
-
Chapter Four: Global IVD Markets
-
General
-
North America
-
Mexico, Central, & South America
-
Brazil
-
Mexico
-
Other Central & South America
-
Argentina
-
Chile
-
Colombia
-
Peru
-
Venezuela
-
All Other Countries & Territories
-
Western Europe
-
France
-
Germany
-
Italy
-
Spain
-
United Kingdom
-
Other Western Europe
-
Austria
-
Belgium
-
Denmark
-
Finland
-
Greece
-
Ireland
-
Norway
-
Netherlands
-
Portugal
-
Sweden
-
Switzerland
-
All Other Countries & Territories
-
Eastern Europe
-
Russia
-
Other Eastern Europe
-
Czech Republic
-
Hungary
-
Poland
-
Romania
-
Ukraine
-
All Other Countries
-
Asia/Pacific
-
China
-
Japan
-
Other Asian Countries and Territories
-
Australia
-
Hong Kong
-
India
-
Indonesia
-
Malaysia
-
Pakistan
-
Philippines
-
Singapore
-
South Korea
-
Taiwan
-
Thailand
-
Vietnam
-
New Zealand
-
All Other Countries & Territories
-
Middle East
-
Turkey
-
Other Middle East
-
Iran
-
Iraq
-
Israel
-
Saudi Arabia
-
United Arab Emirates
-
All Other Countries
-
Africa
-
Nigeria
-
South Africa
-
All Other Countries & Territories
-
Chapter Five: Point-of-Care (POC) Procedures
-
Scope
-
Introduction
-
Point-of-Care (POC) Testing Overview
-
Global POC Procedure Volume by Test Type
-
POC Self Tests
-
Traditional Blood Glucose Monitoring Activities
-
Continuous Blood Glucose Monitoring
-
Pregnancy and Fertility Testing
-
Coagulation Testing
-
Fecal Occult Blood Testing
-
Drugs of Abuse Testing
-
H. pylori Testing
-
HIV Testing
-
Infectious Disease
-
Cholesterol Testing
-
POC Urinalysis Testing
-
Other POC Self-Testing
-
POC Self-Testing Product Sales
-
Pricing Trends
-
POC Professional Testing
-
POC Professional Blood Glucose Testing Procedures
-
POC Professional Critical Care Testing
-
POC Fertility Testing
-
POC Professional Infectious Disease Testing
-
POC Professional Cardiac Marker Testing
-
POC Professional Cholesterol/Lipid Testing
-
POC Professional Coagulation Testing
-
POC Professional HbA1C Testing
-
POC Professional Hematology Testing
-
POC Professional Fecal Occult Blood Screening
-
POC Professional Drugs of Abuse Testing
-
POC Professional Urinalysis Testing
-
Other POC Professional Testing
-
POC IVD Product Sales
-
Pricing Trends
-
Chapter Six: Clinical Chemistry Procedures
-
Scope
-
Introduction
-
Types of Tests
-
General Chemistry
-
Enzymes
-
Glucose
-
Lipids
-
Proteins
-
Other Compounds
-
Blood Gases & Electrolytes
-
Urinalysis
-
Global Sales of Clinical Chemistry Products
-
Pricing Trends
-
Chapter Seven: Immunoassay Procedures
-
Scope
-
Introduction
-
Labeling Techniques
-
Enzyme Immunoassays
-
Chemiluminescent Magnetic Immunoassays (CMIAs)
-
Fluorescence Polarization Immunoassays (FPIAs)
-
Radioimmunoassays (RIAs)
-
Testing Procedures & Product Sales
-
Cardiac Markers
-
Tumor Markers
-
Autoimmune Conditions
-
Allergy Conditions
-
Thyroid Conditions
-
Proteins
-
Alzheimer’s Disease
-
Anemia
-
Fertility Testing
-
Therapeutic Drug Monitoring
-
Vitamin D
-
Diabetes/HbA1c
-
Drugs of Abuse
-
Infectious Diseases
-
Instruments
-
Pricing Trends
-
Chapter Eight: Molecular Testing Procedures
-
Introduction
-
Types of Tests
-
Testing Technologies
-
Infectious Diseases
-
Blood Screening
-
Cancer
-
Transplant Matching
-
Thrombophilia SNPs
-
Inherited Diseases
-
Other Molecular Tests
-
Prenatal
-
Global Sales of Molecular IVD Products
-
Pricing Trends
-
Chapter Nine: Laboratory-Based Hematology Procedures
-
Scope
-
Introduction
-
Types of Tests
-
Global Sales of Hematology Products
-
Pricing Trends
-
Chapter Ten: Coagulation Testing Procedures
-
Introduction
-
Types of Tests
-
Global Sales of Coagulation Products
-
Pricing Trends
-
Chapter Eleven: Microbiology Procedures
-
Scope
-
Introduction
-
Types of Tests
-
ID/AST Automated Panels & Reagents
-
Manual Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Global Sales of Conventional IVD Microbiology Products
-
ID/AST Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Pricing Trends
-
Chapter Twelve: Blood Grouping/Typing Procedures
-
Introduction
-
Types of Tests
-
Blood Grouping/Typing Product Sales
-
Pricing Trends
-
Chapter Thirteen: Histology/Cytology Procedures
-
Scope
-
Introduction
-
Types of Tests
-
Immunohistochemistry Tests
-
In Situ Hybridization Tests
-
Pap Tests
-
Traditional Non-Pap Stains
-
Circulating Tumor Cells
-
Flow Cytometry
-
Histology/Cytology IVD Product Sales
-
Pricing Trends
-
Chapter Fourteen: Company Profiles
-
Introduction
-
Abbott Diagnostics
-
Agilent Technologies
-
Becton, Dickinson and Company (BD)
-
bioMérieux Inc.
-
Bio-Rad Laboratories, Inc.
-
Danaher Corporation
-
Dexcom
-
Diasorin
-
Exact Sciences
-
Hologic, Inc.
-
Illumina
-
Recent Revenue History
-
Recent Revenue History
-
Natera
-
QuidelOrtho Corporation
-
Revvity
-
Roche Diagnostics
-
Siemens Healthineers (Siemens)
-
Sysmex Corporation
-
Thermo Fisher Scientific Inc.
-
Werfen
|
IVD Test Procedure Volumes, 2024-2029
8 Oct 2024
Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends shaping in vitro diagnostic (IVD) procedural volumes. Designed to complement Kalorama’s comprehensive market analysis in The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition, this essential report delivers actionable data on the growth, challenges, and emerging opportunities in the IVD space.
As a rapidly evolving market, the IVD landscape in 2024 is set to thrive, driven by new technologies, evolving healthcare spending, and a surge in demand for precision diagnostics. Our report not only identifies the most significant procedural segments but also breaks down the impact of ongoing innovations.
With this detailed market research, you can stay ahead of industry developments and make informed business decisions. Whether you are looking to expand your product portfolio, explore new market segments, or refine your strategic approach, IVD Test Procedure Volumes, 2024-2029 offers the data and insights you need to succeed.
Why Choose This Report?
- Comprehensive Market Data
Gain an in-depth understanding of IVD procedural volumes by type, region, and country. From self-testing and professional point-of-care (POC) to clinical chemistry, hematology, and beyond—this report covers it all.
- Unmatched Insights into Growth Opportunities
Identify high-growth segments by exploring emerging markets and the potential of precision medicine applications.
- Forward-Looking Analysis
Understand the trends impacting the IVD market, including shifts in regulatory landscapes, new product developments, and changing disease profiles. This report provides a comprehensive forecast from 2024 to 2029.
- Strategic Guidance for Industry Players
Discover how market dynamics, healthcare system trends, and cost pressures are shaping the future of IVD. Use these insights to develop strategies for product positioning, market entry, and growth.
Scope & Methodology
The report includes:
- Global IVD Procedure Volumes by type, covering self and professional POC, clinical chemistry, immunoassay, molecular diagnostics, hematology, coagulation, microbiology, blood banking, and histology/cytology.
- Regional and Country-Specific Data for IVD procedures and their projected growth rates.
- Cost Analysis of various IVD tests to evaluate profitability and potential revenue streams.
Page Count: 405
|
More information about this product
Other Users Also Viewed
25 Jun 2024
Discover Comprehensive Insights with Kalorama’s Clinical Laboratory Services Report
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers…
|
